Cell Technology possesses a customizable ADCC/CDC/CMC assay platform that facilitates the selection of antibody drug candidates. Our bioluminescent ultra sensitive aCella-TOX Assay is rapidly becoming the standard for ADCC/CDC/CMC assays within the therapeutics industry. We provide ADCC/CDC assay services to determine the activity of the antibody and/or complement against specified target cell lines.